UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14D-9
SOLICITATION/RECOMMENDATION STATEMENT
UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934
Translate Bio, Inc.
(Name of Subject Company)
Translate Bio, Inc.
(Name of Persons Filing Statement)
Common Stock, $0.001 par value per share
(Title of Class of Securities)
89374L104
(CUSIP Number of Class of Securities)
Ronald C. Renaud Jr.
President and Chief Executive Officer
Translate Bio, Inc.
29 Hartwell Avenue
Lexington, Massachusetts, 02421
(617) 945-7361
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications
on Behalf of the Persons Filing Statement)
With Copies to:
Krishna Veeraraghavan, Esq.
Paul, Weiss, Rifkind, Wharton & Garrison LLP
1285 Avenue of the Americas
New York, NY 10019-6064
(212) 373-3000
| ☒ | Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
| • | Email to All Employees (Exhibit 99.1) |
| • | Employee FAQ (Exhibit 99.2) |
| • | Letter to Partners and Suppliers (Exhibit 99.3) |
| • | Social Media Posts (Exhibit 99.4) |
